Aurinia Pharmaceuticals Ownership | Who Owns Aurinia Pharmaceuticals?

Overview Forecast RevenueFinancials Chart Transcripts

Aurinia Pharmaceuticals Ownership Summary

Aurinia Pharmaceuticals is owned by 40.12% institutional investors, 7.16% insiders, and 52.72% retail investors. Armistice capital is the largest institutional shareholder, holding 7.73% of AUPH shares. iShares Russell 2000 ETF is the top mutual fund, with 2.40% of its assets in Aurinia Pharmaceuticals shares.

AUPH Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Aurinia Pharmaceuticals	40.12%	7.16%	52.72%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Armistice capital	11.14M	7.73%	$63.59M
Blackrock	9.27M	6.44%	$52.94M
Nea management company	3.97M	2.76%	$22.67M
State street	2.88M	2.00%	$16.45M
Tang capital management	2.78M	1.93%	$15.87M
Goldman sachs group	2.25M	1.57%	$12.87M
Nuveen asset management	1.80M	1.25%	$10.30M
Geode capital management	1.76M	1.22%	$10.07M
Vanguard group	1.54M	1.07%	$8.79M
Rock springs capital management lp	1.18M	0.82%	$6.74M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Nea management company	3.97M	1.71%	$22.67M
Tang capital management	2.78M	1.62%	$15.87M
Armistice capital	11.14M	0.80%	$63.59M
Virtus investment advisers	82.83K	0.40%	$472.95K
Highmark wealth management	91.20K	0.31%	$520.73K
Ironwood investment management	89.86K	0.27%	$513.11K
Rock springs capital management lp	1.18M	0.20%	$6.74M
Virtus etf advisers	61.56K	0.17%	$351.51K
Virtus fund advisers	6.79K	0.15%	$38.76K
Sunbelt securities	160.22K	0.09%	$914.88K

Top Buyers

Holder	Shares	% Assets	Change
Tang capital management	2.78M	1.62%	729.50K
Blackrock	9.27M	0.00%	609.18K
Segall bryant & hamill	553.74K	0.06%	553.74K
Aqr capital management	202.24K	0.00%	202.24K
Jpmorgan chase	507.03K	0.00%	199.10K

Top Sellers

Holder	Shares	% Assets	Change
Armistice capital	11.14M	0.80%	-1.12M
Schroder investment management group	-	-	-997.22K
683 capital management	-	-	-400.00K
Group one trading	-	-	-377.32K
Morgan stanley	987.88K	0.00%	-316.26K

New Positions

Holder	Shares	% Assets	Change	Value
Segall bryant & hamill	553.74K	0.06%	553.74K	$3.16M
Pdt partners	171.35K	0.09%	171.35K	$978.40K
Norges bank	114.05K	0.00%	114.05K	$651.20K
Virtus investment advisers	82.83K	0.40%	82.83K	$472.95K
Corebridge financial	77.24K	0.00%	77.24K	$441.04K

Sold Out

Holder	Change
Vima	-25.00
Nelson, van denburg & campbell wealth management group	-26.00
Walleye trading	-300.00
Lowe wealth advisors	-531.00
Allspring global investments	-595.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	195	7.73%	57,393,945	3.76%	40	2.69%	83	-2.35%	43	-
Jun 30, 2024	180	-8.63%	55,314,751	0.64%	38	2.61%	85	13.33%	42	-32.26%
Mar 31, 2024	197	-6.19%	54,961,177	3.27%	38	2.78%	75	-9.64%	62	1.64%
Dec 31, 2023	210	-2.78%	53,221,003	5.95%	37	3.00%	83	-10.75%	61	22.00%
Sep 30, 2023	216	-1.37%	50,234,131	0.83%	35	2.88%	93	-2.11%	50	-9.09%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
iShares Russell 2000 ETF	3.44M	2.40%	-7.73K
Fidelity Small Cap Index	1.47M	1.03%	-33.65K
International Biotechnology Ord	997.22K	0.70%	-
iShares Biotechnology ETF	908.41K	0.63%	-5.43K
State St Russell Sm/Mid Cp® Indx NL Cl C	900.20K	0.63%	-
iShares Russell 2000 Growth ETF	874.88K	0.61%	-
Nuveen Quant Small Cap Equity R6	847.45K	0.59%	-
GS Glb Sm Cp CORE Eq Base Inc USD Close	620.15K	0.43%	-
Vanguard Russell 2000 ETF	613.39K	0.43%	-3.81K
State St Russell Sm Cap® Indx SL Cl I	493.25K	0.34%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 05, 2024	TANG KEVIN	-	Buy	$2.67M
Dec 09, 2024	TANG KEVIN	-	Buy	$4.54M
Dec 06, 2024	TANG KEVIN	-	Buy	$3.60M
Nov 11, 2024	Bailey Jeffrey Allen	-	Sell	$38.42K
Nov 11, 2024	Smith Karen L.	-	Sell	$44.18K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	3	2
2024 Q3	-	1
2024 Q2	-	5
2024 Q1	-	8
2023 Q3	-	-

AUPH Ownership FAQ

Who Owns Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals shareholders are primarily institutional investors at 40.12%, followed by 7.16% insiders and 52.72% retail investors. The average institutional ownership in Aurinia Pharmaceuticals's industry, Biotech Stocks , is 47.04%, which Aurinia Pharmaceuticals falls below.

Who owns the most shares of Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals’s largest shareholders are Armistice capital (11.14M shares, 7.73%), Blackrock (9.27M shares, 6.44%), and Nea management company (3.97M shares, 2.76%). Together, they hold 16.93% of Aurinia Pharmaceuticals’s total shares outstanding.

Does Blackrock own Aurinia Pharmaceuticals?

Yes, BlackRock owns 6.44% of Aurinia Pharmaceuticals, totaling 9.27M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 52.94M$. In the last quarter, BlackRock increased its holdings by 609.18K shares, a 7.03% change.

Who is Aurinia Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Nea management company is Aurinia Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 1.71% of its assets in 3.97M Aurinia Pharmaceuticals shares, valued at 22.67M$.

Who is the top mutual fund holder of Aurinia Pharmaceuticals shares?

iShares Russell 2000 ETF is the top mutual fund holder of Aurinia Pharmaceuticals shares, with 2.40% of its total shares outstanding invested in 3.44M Aurinia Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools